To examine how the single treatment of NCP and p-FAK/GNP and its combination showed anti-cancer effects, we first performed an immunofluorescence assay against Ki67 protein, a proliferating cell marker (Figure 7, upper panel). The gene discussed is PTK2; the disease is cancer.